Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2615${count})

  • Research Grant, 2025
    A Meta-Analysis of Single Nucleus Allele Specific Expression to Investigate Parkinson's Disease

    Study Rationale: We will study “allele-specific expression” to understand how DNA variants relevant to Parkinson’s disease impact the expression of genes. By looking in each cell, we can check whether...

  • Research Grant, 2025
    Identifying and Pilot Testing Best Practices for Sharing Amyloid PET Research Information with Individuals Living with Lewy Body Diseases

    Study Rationale: Biomarkers are tests that measure something about a person’s health. Research studies often include biomarkers, but research participants may or may not receive the results. This...

  • Research Grant, 2026
    Biofluid Markers in Multiple System Atrophy

    Study Rationale:

    Multiple system atrophy (MSA) and Parkinson’s disease present with similar clinical symptoms, especially at early stages. Though both involve the abnormal accumulation of α-synuclein...

  • Research Grant, 2026
    Parkinson’s Clinical Cohorts Collaborative (PC3)

    Study Rationale:                   

    Effective treatments for the symptoms of Parkinson’s exist, but none slow its progression. Inability to measure or predict future progression are major obstacles to...

  • Research Grant, 2026
    Parallelized Digital Seed Amplification Assay for PD Biomarker Development

    Study Rationale:                  

    The amplification of small quantities of misfolded protein aggregates from clinical samples offers an attractive route towards developing sensitive diagnostics for a...

  • Research Grant, 2026
    Multiscale Measurement of O-GlcNAc Changes in Parkinson’s Disease

    Study Rationale:                   

    Directly targeting the toxic aggregation of α-synuclein by drugs is very challenging. However, this protein is modified by different chemical groups that have the...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.